文献速递呼吸道感染呼吸危重症与机械通气

PROPHETIC研究:ICU住院患者肺炎的前瞻性识别

PROPHETIC: Prospective Identification of Pneumonia in Hospitalized Patients in the ICU.
PubMed 文献 · Chest · 2020-06-29

在28家美国医院ICU中开展前瞻性队列研究,纳入住院超过48小时且需要侵入性或无创通气支持或高浓度吸氧的高危成人患者4,613例,其中32%因疑似院内肺炎接受治疗,但仅37%符合研究肺炎定义;多变量模型识别与院内肺炎风险增加相关的因素,c-statistic为0.709。

要点

  • ICU高呼吸支持患者中院内肺炎治疗常见,但超半数被治疗者不符合标准诊断标准。
  • 创伤或脑血管意外入院、肠内营养、误吸风险及90天内全身抗菌药使用与院内肺炎风险增加相关。
  • 简单临床标准有助于前瞻性识别高危患者,提升肺炎防治临床试验可行性。

核心结论

  • 在ICU接受高水平呼吸支持的高危患者中,院内肺炎治疗常见,但超过半数被治疗者不符合标准诊断标准。
  • 应用简单临床标准可促进前瞻性识别肺炎最高危患者,从而改善肺炎预防和治疗临床试验的可行性。

研究设计与样本

  • 在28家美国医院ICU开展前瞻性队列研究,纳入住院超过48小时且被认为肺炎高风险的成人患者,高风险定义为接受侵入性或无创通气支持或高浓度补充氧治疗。
  • 共纳入4,613例高风险患者;采用多变量logistic回归识别与ICU住院期间肺炎发生风险增加相关的患者特征和治疗暴露。

主要发现

  • 4,613例高风险患者中,1,464例(32%)因可能的院内肺炎接受治疗,其中537例(37%)符合研究肺炎定义。
  • 多变量logistic模型识别与院内肺炎发生风险增加相关的关键患者特征和治疗暴露,c-statistic为0.709(95%CI,0.686-0.731)。
  • 与院内肺炎风险增加相关的关键因素包括创伤或脑血管意外入院诊断、接受肠内营养、有记录的误吸风险及前90天内接受全身抗菌药治疗。

临床怎么用

  • 对ICU内接受高水平呼吸支持的高危患者,可依据创伤或脑血管意外入院、肠内营养、误吸风险及近期全身抗菌药使用等简单临床特征前瞻性识别院内肺炎高危人群。
  • 识别高危患者有助于优化预防措施,并为肺炎预防和治疗临床试验筛选适宜人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pneumonia is the leading infection-related cause of death. The use of simple clinical criteria and contemporary epidemiology to identify patients at high risk of nosocomial pneumonia should enhance prevention efforts and facilitate development of new treatments in clinical trials. RESEARCH QUESTION: What are the clinical criteria and contemporary epidemiology trends that are helpful in the identification of patients at high risk of nosocomial pneumonia? STUDY DESIGN AND METHODS: Within the ICUs of 28 US hospitals, we conducted a prospective cohort study among adults who had been hospitalized >48 hours and were considered high risk for pneumonia (defined as treatment with invasive or noninvasive ventilatory support or high levels of supplemental oxygen). We estimated the proportion of high-risk patients who experienced the development of nosocomial pneumonia. Using multivariable logistic regression, we identified patient characteristics and treatment exposures that are associated with increased risk of pneumonia development during the ICU admission. RESULTS: Between February 6, 2016, and October 7, 2016, 4,613 high-risk patients were enrolled. Among 1,464 high-risk patients (32%) who were treated for possible nosocomial pneumonia, 537 (37%) met the study pneumonia definition. Among high-risk patients, a multivariable logistic model was developed to identify key patient characteristics and treatment exposures that are associated with increased risk of nosocomial pneumonia development (c-statistic, 0.709; 95% CI, 0.686-0.731). Key factors associated with increased odds of nosocomial pneumonia included an admission diagnosis of trauma or cerebrovascular accident, receipt of enteral nutrition, documented aspiration risk, and receipt of systemic antibacterials within the preceding 90 days. INTERPRETATION: Treatment for nosocomial pneumonia is common among patients in the ICU who are receiving high levels of respiratory support, yet more than one-half of patients who are treated do not fulfill standard diagnostic criteria for pneumonia. Application of simple clinical criteria may improve the feasibility of clinical trials of pneumonia prevention and treatment by facilitating prospective identification of patients at highest risk.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Bergin SP, Coles A, Calvert SB, et al. PROPHETIC: Prospective Identification of Pneumonia in Hospitalized Patients in the ICU. Chest. 2020. PMID: 32615191. doi:10.1016/j.chest.2020.06.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。